N@N

Market Maker Surveillance Report. ACHN, ANIP, PTCT, SAEX, DPLO, TRIL, Losing Stocks With Lowest Price Friction For Thursday, N

^{Published on 2016-11-03 18:45:35 - WOPRAI}
 

November 3, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 5406 companies with "abnormal" market making, 2246 companies with positive Friction Factors and 3767 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Thursday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), ANI Pharmaceuticals Inc. (NASDAQ:ANIP), PTC Therapeutics Inc. (NASDAQ:PTCT), SAExploration Holdings Inc. (NASDAQ:SAEX), Diplomat Pharmacy (NYSE:DPLO), Trillium Therapeutics Inc. (NASDAQ:TRIL). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  ACHN    $-1.790   -0.30%    5,384,779    34.38%    6,498,098    41.49%    -1,113,319   -6,220  
  ANIP    $-15.230  -0.25%    274,350      32.42%    277,955      32.84%    -3,605       -2      
  PTCT    $-1.650   -0.27%    2,417,142    39.78%    2,440,452    40.16%    -23,310      -141    
  SAEX    $-2.280   -0.26%    192,967      33.80%    249,708      43.74%    -56,741      -249    
  DPLO    $-9.430   -0.42%    5,803,929    34.20%    6,521,160    38.42%    -717,231     -761    
  TRIL    $-7.850   -0.54%    880,717      34.46%    921,516      36.06%    -40,799      -52     

For example, the chart above shows ACHN with a dollar loss Thursday of $-1.79000 and a Friction Factor of -6,220 shares. That means that it only took 6,220 more shares of selling than buying to move ACHN lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) - Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. Its drug candidates for treating chronic hepatitis C virus (HCV) infection comprise Odalasvir, a NS5A inhibitor, which has completed Phase IIa clinical trials; ACH-3422, a NS5B nucleotide polymerase inhibitor; and Sovaprevir, a NS3 protease inhibitor, which has completed Phase II clinical trial. The company is also developing ACH-4471, a complement factor D inhibitor that is in Phase I clinical trial to treat patients with paroxysmal nocturnal hemoglobinuria and one additional systemic ultra-rare disease; and other factor D inhibitors. It has a license and development agreement with Ora, Inc. for the development and commercialization of ACH-702, an antibacterial drug candidate that is delivered topically or locally; and license and collaboration arrangement with Janssen Pharmaceuticals Inc. to develop and commercialize antiviral drug candidates for treating HCV infection. The company was founded in 1998 and is headquartered in New Haven, Connecticut..

ANI Pharmaceuticals Inc. (NASDAQ:ANIP) - ANIMAL CARE PLAN INC.

PTC Therapeutics Inc. (NASDAQ:PTCT) - PROTECTO INDS INC.

SAExploration Holdings Inc. (NASDAQ:SAEX) - SANHILL EXPLS & DEV.

Diplomat Pharmacy (NYSE:DPLO) - .

Trillium Therapeutics Inc. (NASDAQ:TRIL) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net